CD301b+ dendritic cells suppress T follicular helper cells and antibody responses to protein antigens
Yosuke Kumamoto,
Toshiro Hirai,
Patrick W Wong,
Daniel H Kaplan,
Akiko Iwasaki
Affiliations
Yosuke Kumamoto
Department of Immunobiology, Yale University School of Medicine, New Haven, United States; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States
Toshiro Hirai
Department of Dermatology, University of Pittsburgh, Pittsburgh, United States; Department of Immunology, University of Pittsburgh, Pittsburgh, United States
Patrick W Wong
Department of Immunobiology, Yale University School of Medicine, New Haven, United States; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States
Daniel H Kaplan
Department of Dermatology, University of Pittsburgh, Pittsburgh, United States; Department of Immunology, University of Pittsburgh, Pittsburgh, United States
Department of Immunobiology, Yale University School of Medicine, New Haven, United States; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, United States
Strong antibody response is considered a hallmark of a successful vaccine. While dendritic cells (DCs) are important for T follicular helper (Tfh) cell priming, how this process is regulated in vivo is unclear. We show here that the depletion of CD301b+ DCs specifically enhanced the development of Tfh cells, germinal center B cells and antibody responses against protein antigens. Exaggerated antibody responses in mice depleted of CD301b+ DCs occurred in the absence of any adjuvants, and resulting antibodies had broader specificity and higher affinity to the immunogen. CD301b+ DCs express high levels of PD-1 ligands, PD-L1 and PD-L2. Blocking PD-1 or PD-L1 during priming in wild-type mice partially mimicked the phenotype of CD301b+ DC-depleted animals, suggesting their role in Tfh suppression. Transient depletion of CD301b+ DC results in the generation of autoreactive IgG responses. These results revealed a novel regulatory mechanism and a key role of CD301b+ DCs in blocking autoantibody generation.